Priority Date: 18.09.09 (US 20090243549P)

Thieno[2,3-d]pyridazine derivatives and therapeutic use thereof for protein kinase inhibition

  • Application ID: EP14164666
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorney

operating since 1930
Headquarter in Bremen and 11 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 191 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 18.09.2009 - Priority Date (US 20090243549P)
  • 21.01.2015 - Publication A1 (EP2826780)
  • 01.06.2016 - Publication B1 (EP2826780)

IPC Classification